fbpx

Tag Archives: vaccines

Why India’s COVID-19 vaccine rollout is faltering – podcast

Daniel Merino, The Conversation and Gemma Ware, The Conversation In this episode of The Conversation Weekly podcast, as India’s COVID-19 crisis continues, we look at what’s holding back the country’s vaccination rollout and how a shift in strategy on distribution and pricing is causing concern. And we speak to a researcher who went hunting for fungi in the world’s largest …

Read More »

Can schools require COVID-19 vaccines for students now that Pfizer’s shot is authorized for kids 12 and up?

The Food and Drug Administration on May 10, 2021, granted the first emergency use authorization of a COVID-19 vaccine for adolescents. FG Trade via Getty Images Kristine Bowman, Michigan State University With the first COVID-19 vaccine now authorized for adolescents, ages 12 and up, a big question looms: Will students be required to get the vaccine before returning to their …

Read More »

Cuba’s race to make its own coronavirus vaccine – podcast

Daniel Merino, The Conversation and Gemma Ware, The Conversation In this episode of The Conversation Weekly podcast, how Cuba is pushing ahead with developing its own coronavirus vaccines – and could be nearing “vaccine sovereignty”. And we hear from a researcher about what he learned from asking hundreds of people about the biggest decisions of their lives. Throughout 2020, the …

Read More »

3 mRNA vaccines researchers are working on (that aren’t COVID)

from www.shutterstock.com Archa Fox, The University of Western Australia and Damian Purcell, The Peter Doherty Institute for Infection and Immunity The world’s first mRNA vaccines — the COVID-19 vaccines from Pfizer/BioNTech and Moderna — have made it in record time from the laboratory, through successful clinical trials, regulatory approval and into people’s arms. The high efficiency of protection against severe …

Read More »

South African case study sheds light on how vaccine manufacturing can be developed

Workers pack syringes at India’s biggest syringe manufacturer. Government support has been key to developing this capacity. Photo by Sajjad Hussain/AFP via Getty Images David Richard Walwyn, University of Pretoria and Padmashree Gehl Sampath, Harvard University The uneven availability of COVID-19 vaccines has become an increasingly urgent and vexatious issue. But managing the problem of what’s been labelled “vaccine nationalism” …

Read More »

Backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky – here’s how to make its rollout a success

The concern is about more than one shot vs. two. Michael Ciaglo/Getty Images Tinglong Dai, Johns Hopkins University School of Nursing; Christopher S. Tang, University of California, Los Angeles, and Ho-Yin Mak, University of Oxford More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely …

Read More »